Brief: TetraLogic qtrly loss per share $0.42
Nov 5 (Reuters) - TetraLogic Pharmaceuticals Corp TLOG.O : * Reports third quarter financial results and provides clinical programs update * Qtrly loss per share $0.42 * Q4 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S * Source text for Eikon ID:nGNXVBZPIa * Further company coverage TLOG.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Tetralogic Pharmaceuticals
See all newsNewscasts - Grieving father buries son killed by toxic cough syrup in India
Cellect: Soars on merger deal with Quoin Pharmaceuticals
Brief: Tetralogic announces pacts to restructure convertible debt
Brief: Tetralogic Pharmaceuticals says Pete Meyers resigned as CFO
Brief: TetraLogic Pharmaceuticals says birinapant shows no activity in randomized phase 2 mds study